Pfizer, BioNTech start COVID-flu combination vaccine study

You are here: Home › Pfizer, BioNTech start COVID-flu combination vaccine study

Pfizer, BioNTech start COVID-flu combination vaccine study

2 months ago

U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.

Read more at AOL

Tag: covid cases south africa, us entry requirements covid, covid vaccine heart attack, vaccine requirements to enter us, covid vaccine and heart failure, what happens if you get 3 doses of covid vaccine.